Last reviewed · How we verify

NCT06045728

Telerehabilitation for Overactive Bladder Syndrome in Obese Women

Status unknown NA Last updated 21 September 2023
What this trial tests

NA trial testing Pilates exercises in Overactive Bladder Syndrome in 80 participants. Status unknown.

Timeline
15 September 2023
Primary endpoint
15 December 2023
30 December 2023

Quick facts

Lead sponsorCairo University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment80
Start date15 September 2023
Primary completion15 December 2023
Estimated completion30 December 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 35 to 45, female only, with Overactive Bladder Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Overactive bladder syndrome(OAB) is a chronic medical condition which has a major influence on the quality of life in a significant amount of the population. The goal of this clinical trial study to identify the effect of telerehabilitation program on overactive bladder symptoms and metabolic health in obese women and to compare between the telerehabilitation group and the control group regarding overactive bladder symptoms and metabolic health in obese women.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Pilates exercises

Trials testing the same drug.

Other recruiting trials for Overactive Bladder Syndrome

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06045728.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing